Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease

Background.Diagnosis of invasive fungal disease (IFD) is challenging, and it remains a significant cause of morbidity and mortality in immunocompromised patients. The (1→3)-β-d-glucan (BG) assay may be a useful adjunct, but its diagnostic performance is not well characterized. Methods.We retrospectively assessed the diagnostic indices of the BG assay in patients at risk of IFD who had a compatible clinical syndrome for the diagnosis of IFD a...